Stewart Graham,Ray Bahado-Singh,Michael Maddens,Ali Yilmaz
申请号：
US16633929
公开号：
US20200166526A1
申请日:
2018.07.24
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to methods for diagnosing and/or treating Alzheimer's Disease (AD) by detecting in a human sample the levels of one or more of the metabolites galactose, imidazole acetone, creatinine, and 5-aminopentanoate； diagnosing the patient with AD when one or more of the metabolites galactose, imidazole acetone, creatinine, and 5-aminopentanoate in the sample is at a different level than a statistically validated threshold for the respective metabolite. In some embodiments, the AD is diagnosed and the patient is treated for AD.
